5,260 results match your criteria Europace[Journal]


Differential presentation of atrioventricular nodal re-entrant tachycardia in athletes and non-athletes.

Europace 2019 Feb 14. Epub 2019 Feb 14.

Department of Cardiology, University Hospital Antwerp, Wilrijkstraat 10, Edegem, Belgium.

Aims: Prolonged participation in exercise results in structural and electrical cardiac remodelling. The development of an athlete's heart is recognized as a risk factor for atrial arrhythmias. This study aims to evaluate the impact of athlete heart remodelling on the presentation of atrioventricular nodal re-entrant tachycardia (AVNRT). Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/europace/euz001DOI Listing
February 2019
1 Read

Mechanistic insights from targeted molecular profiling of repolarization alternans in the intact human heart.

Europace 2019 Feb 8. Epub 2019 Feb 8.

Institute of Cardiovascular Science, University College London, London, UK.

Aims: Action potential duration (APD) alternans is an established precursor or arrhythmia and sudden cardiac death. Important differences in fundamental electrophysiological properties relevant to arrhythmia exist between experimental models and the diseased in vivo human heart. To investigate mechanisms of APD alternans using a novel approach combining intact heart and cellular cardiac electrophysiology in human in vivo. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/europace/euz007DOI Listing
February 2019
1 Read

Thoracoscopic maze: yes, we can, but should we?

Authors:
Lluís Mont

Europace 2019 Feb 11. Epub 2019 Feb 11.

Cardiology Department, Cardiovascular Institute, Hospital Clínic, Universitat de Barcelona, Villarroel 170, Barcelona, Catalonia, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/europace/euz014DOI Listing
February 2019

Early experience of thoracoscopic vs. catheter ablation for atrial fibrillation.

Europace 2019 Feb 6. Epub 2019 Feb 6.

Department of Cardiology, Liverpool Heart and Chest Hospital, Thomas Drive, Liverpool, UK.

Aims: Video-assisted thoracoscopic surgery (VATS) ablation has been advocated as a treatment option for non-paroxysmal atrial fibrillation (AF) in recent guidelines. Real-life data on its safety and efficacy during a centre's early experience are sparse.

Methods And Results: Thirty patients (28 persistent/longstanding persistent AF) underwent standalone VATS ablation for AF by an experienced thoracoscopic surgeon, with the first 20 cases proctored by external surgeons. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/europace/euy303DOI Listing
February 2019
1 Read

Omnipolarity applied to equi-spaced electrode array for ventricular tachycardia substrate mapping.

Europace 2019 Feb 4. Epub 2019 Feb 4.

Department of Medicine, Toronto General Hospital, University Health Network, Toronto, Ontario, Canada.

Aims : Bipolar electrogram (BiEGM)-based substrate maps are heavily influenced by direction of a wavefront to the mapping bipole. In this study, we evaluate high-resolution, orientation-independent peak-to-peak voltage (Vpp) maps obtained with an equi-spaced electrode array and omnipolar EGMs (OTEGMs), measure its beat-to-beat consistency, and assess its ability to delineate diseased areas within the myocardium compared against traditional BiEGMs on two orientations: along (AL) and across (AC) array splines.

Methods And Results: The endocardium of the left ventricle of 10 pigs (three healthy and seven infarcted) were each mapped using an Advisor™ HD grid with a research EnSite Precision™ system. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/europace/euy304DOI Listing
February 2019
1 Read
3.050 Impact Factor

Undersensing, asynchronous pacing, and ventricular fibrillation.

Europace 2019 Feb 4. Epub 2019 Feb 4.

Department of Cardiology, Cardiovascular Research Institute Maastricht (CARIM), Maastricht University Medical Center, Maastricht, the Netherlands.

View Article

Download full-text PDF

Source
https://academic.oup.com/europace/advance-article/doi/10.109
Publisher Site
http://dx.doi.org/10.1093/europace/euz009DOI Listing
February 2019
3 Reads

Risk factor modification: another win for our fight against atrial fibrillation.

Europace 2019 Feb 4. Epub 2019 Feb 4.

Department of Cardiovascular Medicine, Heart & Vascular Institute, Cleveland Clinic, Cleveland, OH, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/europace/euz010DOI Listing
February 2019
1 Read

Venous access-site closure with vascular closure device vs. manual compression in patients undergoing catheter ablation or left atrial appendage occlusion under uninterrupted anticoagulation: a multicentre experience on efficacy and complications.

Europace 2019 Feb 4. Epub 2019 Feb 4.

Texas Cardiac Arrhythmia Institute, St. David's Medical Center, 3000 N. I-35, Suite 720, Austin, TX, USA.

Aims: Manual compression (MC), widely used to achieve venous access haemostasis, needs prolonged immobilization and extended time-to-haemostasis. Vascular closure devices (VCD) have been reported to have significantly shorter time to haemostasis and ambulation in arterial access-site management. The current study aimed to evaluate the safety and efficacy as well as rate of urinary tract complications in patients receiving MC vs. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/europace/euz004DOI Listing
February 2019
2 Reads

The importance of identifying conduction breakthrough sites across the mitral isthmus by elaborate mapping for mitral isthmus linear ablation.

Europace 2019 Feb 1. Epub 2019 Feb 1.

Section of Cardiovascular Diseases, Heart Rhythm Institute, University of Oklahoma Health Sciences Center, Oklahoma City, OK, USA.

Aims: Mitral isthmus (MI) ablation is challenging. We hoped to close those conduction breakthrough sites (CBS) across the MI by elaborate mapping.

Methods And Results: After the initial linear ablation, elaborately mapping large areas above and below the MI line and inside the coronary sinus (CS) was sequentially performed to identify the CBS. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/europace/euy327DOI Listing
February 2019

Thoracoscopic vs. catheter ablation for atrial fibrillation: long-term follow-up of the FAST randomized trial.

Europace 2019 Jan 30. Epub 2019 Jan 30.

Department of Cardiothoracic Surgery, Academic Medical Centre, Amsterdam, the Netherlands.

Aims: Our objectives were to compare effectiveness and long-term prognosis after epicardial thoracoscopic atrial fibrillation (AF) ablation vs. endocardial catheter ablation, in patients with prior failed catheter ablation or high risk of failure.

Methods And Results: Patients were randomized to thoracoscopic or catheter ablation, consisting of pulmonary vein isolation with optional additional lines (2007-2010). Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/europace/euy325DOI Listing
January 2019
1 Read

Leadless pacemaker implantation via azygos vein in a patient with absence of the hepatic segment of the inferior vena cava.

Europace 2019 Jan 30. Epub 2019 Jan 30.

Arrhythmology Unit, Santa Marta Hospital, Rua Santa Marta, 1169-024, Lisbon, Portugal.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/europace/euy274DOI Listing
January 2019
1 Read

Clinical impact of speckle tracking echocardiography for detecting the origin of posterior papillary muscle ventricular arrhythmia.

Europace 2019 Jan 30. Epub 2019 Jan 30.

Department of Cardiovascular Medicine, Fukushima Medical University, 1 Hikarigaoka, Fukushima, 960-1295, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/europace/euy328DOI Listing
January 2019
1 Read

Lead extraction for reduction of chronic pain related to cardiovascular implantable electronic device.

Europace 2019 Jan 28. Epub 2019 Jan 28.

Department of Cardiac Electrophysiology, University of California, San Diego Health System, 9452 Medical Center Drive, La Jolla, CA, USA.

Aims: Chronic pain at the cardiovascular implantable electronic device (CIED) generator or lead insertion site that is not otherwise manageable carries a IIA indication for extraction. However, limited data exist evaluating causes of pain and outcomes of extraction in eliminating pain. A multi-centre retrospective observational study was conducted to evaluate outcomes of patients undergoing device extraction for treatment of chronic device pain. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/europace/euy320DOI Listing
January 2019

Repeat procedure is a new independent predictor of complications of atrial fibrillation ablation.

Europace 2019 Jan 25. Epub 2019 Jan 25.

Cardiology Department, Heart and Vascular Center, Semmelweis University, Városmajor Street 68, Budapest, Hungary.

Aims: Atrial fibrillation (AF) ablation has made huge progress with respect to innovation, efficacy, and safety, however, complications are still present. Recent studies examined various predictors of complications. However, limited data exist regarding the role of a repeat procedure. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/europace/euy326DOI Listing
January 2019
2 Reads

Thoracoscopic ablation for the treatment of atrial fibrillation: a systematic outcome analysis of a multicentre cohort.

Europace 2019 Jan 25. Epub 2019 Jan 25.

Department of Cardiothoracic Surgery, St. Antonius Hospital, Koekoekslaan 1, CM Nieuwegein, the Netherlands.

Aims: To perform a systematic outcome analysis in order to provide cardiologists and general pactitioners with more adequate information to guide their decision making regarding rhythm control. Totally thoracoscopic maze (TTmaze) for the treatment of atrial fibrillation (AF) is recommended as a Class 2a indication mainly based on single centre studies including small patient cohorts and inconsistent lesion sets.

Methods And Results: We studied consecutive patients undergoing TTmaze in three European referral centres (2012-15). Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/europace/euy323DOI Listing
January 2019
1 Read

Catheter-driven His bundle pacemaker lead implantation.

Europace 2019 Jan 23. Epub 2019 Jan 23.

Abbott Medical, 100 Abbott Park Road, Abbott Park, IL, USA.

Delivery of leads to the His bundle pacing region is most commonly performed with non-deflectable or deflectable sheaths and a His lead with an exposed helix. We present a technique where any pacing lead may be delivered to the His region utilizing a catheter- and snare-delivered approach. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/europace/euy317DOI Listing
January 2019

Protamine reversal of heparin: a fishy practice?

Europace 2019 Jan 25. Epub 2019 Jan 25.

Duke Heart Center, Duke University School of Medicine, Durham, NC, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/europace/euy315DOI Listing
January 2019

Risk of death without appropriate defibrillator shock in patients with advanced renal dysfunction.

Europace 2019 Jan 23. Epub 2019 Jan 23.

Department of Cardiology, Sheba Medical Center, Davidai Arrhythmia Center Leviev Heart Center, 5265601 Tel Hashomer, Ramat Gan, Israel.

Aims: Heart failure patients with advanced chronic kidney disease (CKD) may experience an increased rate of non-arrhythmic mortality due to associated comorbidities. We aimed to evaluate the risk of mortality without appropriate implantable cardioverter-defibrillator (ICD) shocks in this high-risk population.

Methods And Results: The study population comprised 3542 patients who received an ICD, were enrolled, and prospectively followed-up in the Israeli ICD registry. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/europace/euy305DOI Listing
January 2019
2 Reads

Lead extraction in patients with cardiac resynchronization therapy devices: are they worse than the others?

Europace 2019 Jan 18. Epub 2019 Jan 18.

Division of Cardiology, Johns Hopkins Hospital, 600 N. Wolfe St./Carnegie 584, Baltimore, MD 21287, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/europace/euy322DOI Listing
January 2019

ELECTRa-from myth to aletheia: risk factors for transvenous lead extraction in the ancillary analysis of the European Lead Extraction ConTRolled (ELECTRa) study.

Europace 2019 Jan 18. Epub 2019 Jan 18.

VCU Pauley Heart Center at the VCU School of Medicine, Richmond, VA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/europace/euy324DOI Listing
January 2019
1 Read

Leadless pacing using the transcatheter pacing system (Micra TPS) in the real world: initial Swiss experience from the Romandie region-Authors' reply.

Europace 2019 Feb;21(2):357

Cardiology Department, University Hospital of Geneva, Rue Gabrielle Perret Gentil 4, 1205 Geneva, Switzerland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/europace/euy321DOI Listing
February 2019
1 Read

Perioperative bridging of vitamin K antagonist treatment in patients with atrial fibrillation: only a very small group of patients benefits.

Europace 2019 Jan 12. Epub 2019 Jan 12.

Department of Health Sciences, University of Groningen, University Medical Center, Groningen, The Netherlands.

Aims: Bridging anticoagulation in atrial fibrillation (AF) patients who need to interrupt vitamin K antagonists for procedures is a clinical dilemma. Currently, guidelines recommend clinicians to take the stroke and bleeding risk into consideration, but no clear thresholds are advised. To aid clinical decision making, we aimed to develop a model in which periprocedural bridging therapy is compared with withholding anticoagulation in AF patients, for several bleeding and stroke risk groups. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/europace/euy308DOI Listing
January 2019
3 Reads

Three-dimensional cardiac fibre disorganization as a novel parameter for ventricular arrhythmia stratification after myocardial infarction.

Europace 2019 Jan 12. Epub 2019 Jan 12.

Centro Nacional de Investigaciones Cardiovasculares (CNIC), Myocardial Pathophysiology Area, Melchor Fernández Almagro 3, Madrid 28029, Spain.

Aims: Myocardial infarction (MI) alters cardiac fibre organization with unknown consequences on ventricular arrhythmia. We used diffusion tensor imaging (DTI) of three-dimensional (3D) cardiac fibres and scar reconstructions to identify the main parameters associated with ventricular arrhythmia inducibility and ventricular tachycardia (VT) features after MI.

Methods And Results: Twelve pigs with established MI and three controls underwent invasive electrophysiological characterization of ventricular arrhythmia inducibility and VT features. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/europace/euy306DOI Listing
January 2019
2 Reads
3.050 Impact Factor

Erratum.

Authors:

Europace 2019 Jan 10. Epub 2019 Jan 10.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/europace/euy302DOI Listing
January 2019
1 Read

Comparison between linear and focal ablation of complex fractionated atrial electrograms in patients with non-paroxysmal atrial fibrillation: a prospective randomized trial.

Europace 2019 Jan 12. Epub 2019 Jan 12.

Division of Cardiology, Department of Internal Medicine, Korea University Medical Center, 73 Inchon-ro, Seongbuk-gu, Seoul 02841, Republic of Korea.

Aims: Findings regarding efficacy of substrate modification for non-paroxysmal atrial fibrillation (AF) are inconsistent. We prospectively compared clinical outcomes of complex fractionated atrial electrogram (CFAE)-guided focal ablation (CFA) and CFAE-guided linear ablation (CLA) in patients with non-paroxysmal AF.

Methods And Results: We randomized 150 patients with non-paroxysmal AF into CFA and CLA groups in a 1:1 ratio. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/europace/euy313DOI Listing
January 2019
2 Reads

Cardiac arrest following protamine administration: a case series.

Europace 2019 Jan 10. Epub 2019 Jan 10.

Cardiology Clinical Academic Group, St. George's University Hospitals NHS Foundation Trust, St. George's, University of London, London, UK.

Aims: Protamine sulfate is commonly used to reverse the action of heparin after catheter ablation procedures. Serious protamine-related adverse effect is rare, but its recognition and appropriate management by electrophysiologists and intensivists is important. Direct ventricular fibrillation (VF) soon after a slow infusion of protamine has not been clearly described. Read More

View Article

Download full-text PDF

Source
https://academic.oup.com/europace/advance-article/doi/10.109
Publisher Site
http://dx.doi.org/10.1093/europace/euy288DOI Listing
January 2019
14 Reads

Reproducibility and accuracy of late gadolinium enhancement cardiac magnetic resonance measurements for the detection of left atrial fibrosis in patients undergoing atrial fibrillation ablation procedures.

Europace 2019 Jan 10. Epub 2019 Jan 10.

Arrhythmia Unit, Department of Cardiology, Cardiovascular Clinical Institute, UFA (Unitat de Fibril·lació Auricular de l'Hospital Clínic), Hospital Clínic, Universitat de Barcelona, IDIBAPS (Institut d'Investigació Biomèdica August Pi i Sunyer), C/Villarroel N° 170, 08036 Barcelona, Spain.

Aims: Late gadolinium enhancement cardiac magnetic resonance (LGE-CMR) may define left atrial (LA) anatomy and structural remodelling, and facilitate atrial fibrillation (AF) ablation. We aimed to assess the intra- and inter-observer reproducibility and agreement of LGE-CMR parameters with direct application to AF ablation techniques.

Methods And Results: One experienced and one non-experienced observer performed complete LGE-CMR data analysis twice, on different days, in 40 randomly selected LGE-CMR examinations [20 performed before ablation (pre-ablation) and 20 performed 3 months after ablation (post-ablation)]. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/europace/euy314DOI Listing
January 2019
1 Read

Effect of PR interval and pacing mode on persistent atrial fibrillation incidence in dual chamber pacemaker patients: a sub-study of the international randomized MINERVA trial.

Europace 2019 Jan 10. Epub 2019 Jan 10.

Department of Experimental, Diagnostic and Specialty Medicine, University of Bologna, S.Orsola-Malpighi University Hospital, Bologna, Italy.

Aims: Per standard of care, dual-chamber pacemakers are programmed in DDDR mode with fixed atrioventricular (AV) delay or with long AV delay to minimize ventricular pacing. We aimed to evaluate whether the PR interval may be a specific criterion of choice between standard DDDR, to preserve AV synchrony in long PR patients, and managed ventricular pacing (MVP), to avoid ventricular desynchronization imposed by right ventricle apical pacing, in short PR patients.

Methods And Results: In the MINERVA trial, 1166 patients were randomized to Control DDDR, MVP, or atrial anti-tachycardia pacing plus MVP (DDDRP + MVP). Read More

View Article

Download full-text PDF

Source
https://academic.oup.com/europace/advance-article/doi/10.109
Publisher Site
http://dx.doi.org/10.1093/europace/euy286DOI Listing
January 2019
8 Reads
3.050 Impact Factor

Ultra-high density electroanatomic mapping of left atrial local macro-reentry occurring twenty-three years after orthotopic heart transplantation.

Europace 2019 Jan 10. Epub 2019 Jan 10.

Department of Cardiology, Caen Regional University Hospital, Avenue de la Côte de Nacre, Caen, Normandy, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/europace/euy309DOI Listing
January 2019
2 Reads

Targeted therapy of underlying conditions improves quality of life in patients with persistent atrial fibrillation: results of the RACE 3 study.

Europace 2019 Jan 9. Epub 2019 Jan 9.

Department of Cardiology, University Medical Centre Groningen, University of GroningenRB Groningen, Netherlands.

Aims: Atrial fibrillation (AF) reduces quality of life (QoL). We aim to evaluate effects of targeted therapy of underlying conditions on QoL in patients with AF and heart failure (HF).

Methods And Results: The Routine versus Aggressive risk factor driven upstream rhythm Control for prevention of Early atrial fibrillation in heart failure (RACE 3) study randomized patients with early persistent AF and HF to targeted or conventional therapy. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/europace/euy311DOI Listing
January 2019
6 Reads

Risk factors for atrioventricular block after transcatheter aortic valve implantation: a single-centre analysis including assessment of aortic calcifications and follow-up.

Europace 2019 Jan 9. Epub 2019 Jan 9.

Department of Cardiac Surgery, Cardiovascular Center, Klinikum Nürnberg - Paracelsus Medical University, Breslauer Str. 201, Nuremberg, Germany.

Aims: To assess the contribution of aortic valve calcification to the occurrence of transient or permanent atrioventricular block (AVB) and the need for permanent pacemaker implantation (PPI) after transcatheter aortic valve implantation (TAVI) in a large single-centre cohort.

Methods And Results: We retrospectively analysed pre-operative contrast-enhanced multidetector computed tomography scans of patients who underwent TAVI in our centre between 2012 and 2016. Calcium volume was calculated for each aortic cusp above (aortic valve), and below [left ventricular outflow tract (LVOT)] the basal plane. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/europace/euy316DOI Listing
January 2019
9 Reads

Successful slow pathway ablation in a patient with an interrupted inferior vena cava and persistent left superior vena cava.

Europace 2019 Jan 9. Epub 2019 Jan 9.

Division of Cardiovascular Disease, Department of Pediatric Cardiology, University of Alabama at Birmingham, FOT 930A, 510 20th Street South, Birmingham, AL 35294-0019, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/europace/euy312DOI Listing
January 2019
1 Read

Procedural outcomes associated with transvenous lead extraction in patients with abandoned leads: an ESC-EHRA ELECTRa (European Lead Extraction ConTRolled) Registry Sub-Analysis.

Europace 2019 Jan 9. Epub 2019 Jan 9.

Clinique Pasteur, Management of Cardiac Arrhythmias, 45 Avenue de Lombez, 33300 Toulouse, France.

Aims: The decision to abandon or extract superfluous leads remains controversial. We sought to compare procedural outcome of patients with and without abandoned leads undergoing transvenous lead extraction (TLE).

Methods And Results: An analysis of the ESC-EHRA European Lead Extraction ConTRolled ELECTRa registry was conducted. Read More

View Article

Download full-text PDF

Source
https://academic.oup.com/europace/advance-article/doi/10.109
Publisher Site
http://dx.doi.org/10.1093/europace/euy307DOI Listing
January 2019
5 Reads

His-bundle pacing: promise for the future.

Europace 2019 Jan 9. Epub 2019 Jan 9.

Heart Center-University of Leipzig, Leipzig, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/europace/euy318DOI Listing
January 2019
1 Read

Radiofrequency ablation of right ventricular tachycardia in patients with no femoral access: safety and efficacy of a superior approach.

Europace 2019 Jan 8. Epub 2019 Jan 8.

Univ Rennes, France.

Aims: Ventricular tachycardia (VT) ablation has been proven to be effective and safe to avoid arrhythmia recurrences in patients with repaired congenital heart disease (CHD). However, some of these patients may present right ventricular (RV) access issues [agenesia or thrombosis of inferior vena cava (IVC)], making impossible to access the right ventricle through an inferior approach. In such patients, only a superior approach would theoretically be feasible. Read More

View Article

Download full-text PDF

Source
https://academic.oup.com/europace/advance-article/doi/10.109
Publisher Site
http://dx.doi.org/10.1093/europace/euy298DOI Listing
January 2019
2 Reads

Cardiac magnetic resonance in patients with cardiac resynchronization therapy: is it time to scan with resynchronization on?

Europace 2019 Jan 3. Epub 2019 Jan 3.

Leeds Institute of Cardiovascular and Metabolic Medicine, Light Laboratories, University of Leeds and Leeds Teaching Hospitals NHS Trust, Clarendon Way, Leeds LS2 9NL, UK.

Cardiac resynchronization therapy (CRT) is recommended in international guidelines for patients with heart failure due to important left ventricular systolic dysfunction (or heart failure with reduced ejection fraction) and ventricular conduction tissue disease. Cardiac magnetic resonance (CMR) represents the most powerful imaging tool for dynamic assessment of the volumes and function of cardiac chambers but is rarely utilized in patients with CRT due to limitations on the device, programming and scanning. In this review, we explore the known utility of CMR in this cohort with discussion of the risks and potential benefits of scanning whilst CRT is active, including a practical strategy for conducting high quality scans safely. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/europace/euy299DOI Listing
January 2019
1 Read

Role of medical reaction in management of inappropriate ventricular arrhythmia diagnosis: the inappropriate Therapy and HOme monitoRiNg (THORN) registry.

Europace 2019 Jan 2. Epub 2019 Jan 2.

Department of Cardiology, Centre Hospitalier Universitaire La Timone, F-13385 Marseille, France.

Aims: Implantable cardioverter-defibrillators (ICDs) reduce sudden cardiac death in selected patients but inappropriate ICD shocks have been associated with increased mortality. The THORN registry aims to describe the rate of inappropriate ventricular arrhythmia diagnoses and therapies in patients followed by remote monitoring, as well as the following delay to next patient contact (DNPC).

Methods And Results: One thousand eight hundred and eighty-two patients issued from a large remote monitoring database first implanted with an ICD for primary or secondary prevention in 110 French hospitals from 2007 to 2014 constitute the THORN population. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/europace/euy284DOI Listing
January 2019
3 Reads

Time-to-first appropriate shock in patients implanted prophylactically with an implantable cardioverter-defibrillator: data from the Survey on Arrhythmic Events in BRUgada Syndrome (SABRUS).

Europace 2018 Dec 24. Epub 2018 Dec 24.

Department of Cardiology, Leviev Heart Institute, The Chaim Sheba Medical Center, Tel Hashomer, and Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel.

Aims: Data on predictors of time-to-first appropriate implantable cardioverter-defibrillator (ICD) therapy in patients with Brugada Syndrome (BrS) and prophylactically implanted ICD's are scarce.

Methods And Results: SABRUS (Survey on Arrhythmic Events in BRUgada Syndrome) is an international survey on 678 BrS patients who experienced arrhythmic event (AE) including 252 patients in whom AE occurred after prophylactic ICD implantation. Analysis was performed on time-to-first appropriate ICD discharge regarding patients' characteristics. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/europace/euy301DOI Listing
December 2018
9 Reads
3.050 Impact Factor

Major cardiac and vascular complications after transvenous lead extraction: acute outcome and predictive factors from the ESC-EHRA ELECTRa (European Lead Extraction ConTRolled) registry.

Europace 2018 Dec 27. Epub 2018 Dec 27.

Second Department of Cardiology, Cardiac Thoracic and Vascular Department - University Hospital of Pisa, Via Paradisa, 2, 56124, Cisanello, Italy.

Aims: We aimed at describing outcomes and predictors of cardiac avulsion or tear (CA/T) with tamponade and vascular avulsion or tear (VA/T) after transvenous lead extraction (TLE) in the ESC-EHRA European Lead Extraction ConTRolled (ELECTRa) registry.

Methods And Results: A total of 3555 consecutive patients of whom 3510 underwent TLE at 73 centres in 19 European countries were enrolled. Among 58 patients (1. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/europace/euy300DOI Listing
December 2018
3 Reads

Transvenous lead extraction in patients with cardiac resynchronization therapy devices is not associated with increased 30-day mortality.

Europace 2018 Dec 24. Epub 2018 Dec 24.

Department of Cardiology, Lower Ground Floor, South Wing, Guy's and St Thomas' NHS Foundation Trust, Westminster Bridge Road, London, UK.

Aims: Transvenous lead extraction (TLE) may be necessary due to system infection/erosion or lead malfunction. Cardiac resynchronization therapy (CRT) patients undergoing TLE may be at greater risk due to increased comorbidities. We examined whether patients with CRT systems undergoing TLE had more comorbidities and higher 30-day mortality than those with non-CRT devices. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/europace/euy290DOI Listing
December 2018
1 Read

Inappropriate shock caused by programming of a slow ventricular tachycardia-zone with anti-tachycardia pacing only: a case report.

Europace 2019 Jan;21(1):72

Department of Cardiology B, Rigshospitalet, Blegdamsvej 9, Copenhagen OE, Denmark.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/europace/euy280DOI Listing
January 2019
1 Read

Survival after cardiac resynchronization therapy: results from 50 084 implantations.

Europace 2018 Dec 27. Epub 2018 Dec 27.

Queen Elizabeth Hospital, Birmingham, UK.

Aims: Randomized controlled trials have shown that cardiac resynchronization therapy (CRT) prolongs survival in patients with heart failure. No studies have explored survival after CRT in relation to individuals in the general population (relative survival, RS). We sought to determine observed and RS after CRT in a nationwide cohort undergoing CRT. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/europace/euy267DOI Listing
December 2018
3 Reads

Cardiac resynchronization therapy: need to synchronize patients and device longevities with comorbidities.

Europace 2018 Dec 27. Epub 2018 Dec 27.

Clinical Cardiovascular Research Center, University of Rochester Medical Center, 265 Crittenden Blvd., Box 653, Rochester, NY 14642, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/europace/euy297DOI Listing
December 2018
1 Read

Real-world costs of transvenous lead extraction: the challenge for reimbursement.

Europace 2019 Feb;21(2):290-297

Institute of Cardiovascular Medicine and Science at Liverpool Heart and Chest Hospital, Thomas Drive, Liverpool, UK.

Aims: Transvenous lead extraction is challenging, often requiring specialist equipment and prolonged hospital admission. A single tariff or itemized costs may be available for reimbursement. Due to limited data relating to the costs of transvenous extraction, it is unclear whether either form of reimbursement is adequate. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/europace/euy291DOI Listing
February 2019
1 Read
3.050 Impact Factor

Non-invasive electrocardiographic imaging of His-bundle and peri-left bundle pacing in left bundle branch block.

Europace 2018 Dec 24. Epub 2018 Dec 24.

Department of Medicine and Therapeutics, Prince of Wales Hospital, Chinese University of Hong Kong, 30-32 Ngan Shing Street, Shatin, Hong Kong.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/europace/euy293DOI Listing
December 2018
5 Reads

Interpolated Purkinje potentials recorded at a successful ablation site of a fascicular premature ventricular contraction during sinus rhythm.

Europace 2018 Dec 24. Epub 2018 Dec 24.

Department of Cardiology, Hirosaki University Graduate School of Medicine, 5 Zaifu-cho, Hirosaki, Aomori, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/europace/euy296DOI Listing
December 2018
2 Reads

Integration of cardiac magnetic resonance imaging, electrocardiographic imaging, and coronary venous computed tomography angiography for guidance of left ventricular lead positioning.

Europace 2018 Dec 24. Epub 2018 Dec 24.

Department of Cardiology, CARIM, Maastricht University Medical Center, Maastricht, the Netherlands.

Aims: An appropriate left ventricular (LV) lead position is a pre-requisite for response to cardiac resynchronization therapy (CRT) and is highly patient-specific. The purpose of this study was to develop a non-invasive pre-procedural CRT-roadmap to guide LV lead placement to a coronary vein in late-activated myocardium remote from scar.

Methods And Results: Sixteen CRT candidates were prospectively included. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/europace/euy292DOI Listing
December 2018
2 Reads